Norfloxacin as a model hydrophobic drug with unique release from liquisolid formulations prepared with PEG200 and Synperonic PE/L-61 non-volatile liquid vehicles-Reference-Cited by-同舟云学术

Norfloxacin as a model hydrophobic drug with unique release from liquisolid formulations prepared with PEG200 and Synperonic PE/L-61 non-volatile liquid vehicles

Published:2014-05 Issue: Volume:257 Page:156-167
ISSN:0032-5910
Container-title:Powder Technology
language:en
Short-container-title:Powder Technology

Author:

Suliman Ammar Said,Anderson Rosaleen J.,Elkordy Amal Ali

Publisher

Elsevier BV

Subject

General Chemical Engineering

Reference23 articles.

1. Pharmaceutical technologies for enhancing oral bioavailability of poorly soluble drugs;Krishnaiah;J. Bioequivalence Bioavailab.,2010

2. Drug Solubility: Importance and Enhancement Techniques, ISRN Pharmaceutics;Savjani,2012

3. Solubility enhancement—eminent role in poorly soluble drugs;Sharma;Res. J. Pharm. Tech.,2009

4. A comparative study of artificial membrane permeability assay for high throughput profiling of drug absorption potential;Zhu;Eur. J. Med. Chem.,2002

5. Prediction of human absorption of natural compounds by the non-everted rat intestinal sac model;Ruana;Eur. J. Med. Chem.,2006

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Functionalized xanthohumol nanoemulsion: fabrication, characterization and bioavailability enhancement of bioactive compounds;Journal of the Science of Food and Agriculture;2024-07-31

2. Liquisolids: A Modernistic approach in Drug Delivery System;Asian Journal of Research in Pharmaceutical Sciences;2024-03-02

3. Stable nanoemulsions for poorly soluble curcumin: From production to digestion response in vitro;Journal of Molecular Liquids;2024-01

4. Surfactant vesicles for enhanced antitoxoplasmic effect of norfloxacin: In vitro and in vivo evaluations;International Journal of Pharmaceutics;2023-05

5. Andrographolide Liquisolid using Porous-Starch as the Adsorbent with Enhanced Oral Bioavailability in Rats;Journal of Pharmaceutical Sciences;2023-02